Antidepressant medication use and nasopharyngeal cancer risk: a nationwide population-based study

References

• DavidsonJRMajor depressive disorder treatment guidelines in America and EuropeJ Clin Psychiatry201071Suppl E1e04
   PubMedGoogle Scholar
• KellnerMDrug treatment of obsessive-compulsive disorderDialogues Clin Neurosci201012218719720623923
   PubMedGoogle Scholar
• RuepertLQuarteroAOde WitNJvan der HeijdenGJRubinGMurisJWBulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndromeCochrane Database Syst Rev20118CD00346021833945
   PubMed Web of Science ®Google Scholar
• KantorEDRehmCDHaasJSChanATGiovannucciELTrends in prescription drug use among adults in the United States from 1999–2012JAMA2015314171818183126529160
   PubMed Web of Science ®Google Scholar
• AmerioAGalvezJFOdoneADalleySAGhaemiSNCarcinogenicity of psychotropic drugs: a systematic review of US Food and Drug Administration-required preclinical in vivo studiesAust N Z J Psychiatry201549868669625916799
   PubMed Web of Science ®Google Scholar
• HsiehYHChiuWCLinCFAntidepressants and gastric cancer: a nationwide population-based nested case-control studyPLoS One20151011e014366826606417
   PubMed Web of Science ®Google Scholar
• ChanHLHsiehYHLinCFInvasive cervical cancer and antidepressants: a nationwide population-based studyMedicine (Baltimore)20159442e186626496343
   PubMed Web of Science ®Google Scholar
• ChubakJBoudreauDMRulyakSJMandelsonMTColorectal cancer risk in relation to antidepressant medication useInt J Cancer2011128122723220232382
   PubMed Web of Science ®Google Scholar
• ChenVCLinCFHsiehYHHepatocellular carcinoma and antidepressants: a nationwide population-based studyOncotarget2017818304643047027783998
   PubMedGoogle Scholar
• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
   PubMed Web of Science ®Google Scholar
• YoungLSDawsonCWEpstein-Barr virus and nasopharyngeal carcinomaChin J Cancer2014331258159025418193
   PubMedGoogle Scholar
• PohSSChuaMLWeeJTCarcinogenesis of nasopharyngeal carcinoma: an alternate hypothetical mechanismChin J Cancer2016351926738743
   PubMedGoogle Scholar
• JiaWHQinHDNon-viral environmental risk factors for nasopharyngeal carcinoma: a systematic reviewSemin Cancer Biol201222211712622311401
   PubMed Web of Science ®Google Scholar
• ChuaMLKWeeJTSHuiEPChanATCNasopharyngeal carcinomaLancet2016387100221012102426321262
   PubMed Web of Science ®Google Scholar
• KinjoTKowalczykPKowalczykMDesipramine inhibits the growth of a mouse skin squamous cell carcinoma cell line and affects glucocorticoid receptor-mediated transcriptionMol Carcinog200948121123113019575421
   PubMed Web of Science ®Google Scholar
• WacholderSSilvermanDTMcLaughlinJKMandelJSSelection of controls in case-control studies. III. Design optionsAm J Epidemiol19921359104210501595690
   PubMed Web of Science ®Google Scholar
• WHOCollaborating Centre for Drug Statistics Methodology, ATC Classification Index with DDDs. (2013)2013 Available from: http://www.whocc.no/atc_ddd_publications/atc_ddd_index/Accessed July 10, 2014
   Google Scholar
• Di MasoMBosettiCLa VecchiaCRegular aspirin use and nasopharyngeal cancer risk: a case-control study in ItalyCancer Epidemiol201539454554725960427
   PubMed Web of Science ®Google Scholar
• AshburyJELevesqueLEBeckPAAronsonKJA population-based case-control study of Selective Serotonin Reuptake Inhibitors (SSRIs) and breast cancer: the impact of duration of use, cumulative dose and latencyBMC Med201089021176215
   PubMed Web of Science ®Google Scholar
• WernliKJHamptonJMTrentham-DietzANewcombPAAntidepressant medication use and breast cancer riskPharmacoepidemiol Drug Saf200918428429019226540
   PubMed Web of Science ®Google Scholar
• HarlowBLCramerDWSelf-reported use of antidepressants or benzodiazepine tranquilizers and risk of epithelial ovarian cancer: evidence from two combined case-control studies (Massachusetts, United States)Cancer Causes Control1995621301347749052
   PubMed Web of Science ®Google Scholar
• WuCSLuMLLiaoYTLeeCTChenVCOvarian cancer and antidepressantsPsychooncology201524557958425335924
   PubMed Web of Science ®Google Scholar
• CooganPFRosenbergLPalmerJRRisk of ovarian cancer according to use of antidepressants, phenothiazines, and benzodiazepines (United States)Cancer Causes Control200011983984511075873
   PubMed Web of Science ®Google Scholar
• HaukkaJSankilaRKlaukkaTIncidence of cancer and antidepressant medication: record linkage studyInt J Cancer2010126128529619739257
   PubMed Web of Science ®Google Scholar
• AzmitiaECModern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosisBrain Res Bull200156541342411750787
   PubMed Web of Science ®Google Scholar
• CosgroveLShiLCreaseyDEAnaya-McKiverganMMyersJAHuybrechtsKFAntidepressants and breast and ovarian cancer risk: a review of the literature and researchers’ financial associations with industryPLoS One201164e1821021494667
   PubMed Web of Science ®Google Scholar
• FrickLRRapanelliMAntidepressants: influence on cancer and immunity?Life Sci2013921052553223369745
   PubMed Web of Science ®Google Scholar
• Gil-AdIZolokovALomnitskiLEvaluation of the potential anticancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted miceInt J Oncol200833227728618636148
   PubMed Web of Science ®Google Scholar
• FangYCChouCTPanCCParoxetine-induced Ca2+ movement and death in OC2 human oral cancer cellsChin J Physiol201154531031722135909
   PubMed Web of Science ®Google Scholar
• HsuWLChenJYChienYCIndependent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in TaiwanCancer Epidemiol Biomarkers Prev20091841218122619336547
   PubMed Web of Science ®Google Scholar